# MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery

> **NCT04327063** · PHASE3 · COMPLETED · sponsor: **Institut Curie** · enrollment: 182 (actual)

## Conditions studied

- Malignant Neoplasm of Breast

## Interventions

- **DRUG:** Saline
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT04327063
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-04
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-01-28
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04327063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04327063, "MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04327063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*